DYRK1A inhibitors for disease therapy: Current status and perspectives

T Liu, Y Wang, J Wang, C Ren, H Chen… - European journal of …, 2022 - Elsevier
Dual-specificity tyrosine phosphorylation-regulated kinase 1 A (DYRK1A) is a conserved
protein kinase that plays essential roles in various biological processes. It is located in the …

DYRK1A and cognition: A lifelong relationship

ML Arbones, A Thomazeau… - Pharmacology & …, 2019 - Elsevier
The dosage of the serine threonine kinase DYRK1A is critical in the central nervous system
(CNS) during development and aging. This review analyzes the functions of this kinase by …

DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics

L Zhuang, K Jia, C Chen, Z Li, J Zhao, J Hu, H Zhang… - Circulation, 2022 - Am Heart Assoc
Background: Heart failure is a global public health issue that is associated with increasing
morbidity and mortality. Previous studies have suggested that mitochondrial dysfunction …

DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3

RS Bhansali, M Rammohan, P Lee… - The Journal of …, 2021 - Am Soc Clin Investig
DYRK1A is a serine/threonine kinase encoded on human chromosome 21 (HSA21) that has
been implicated in several pathologies of Down syndrome (DS), including cognitive deficits …

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

A Duchon, Y Herault - Frontiers in behavioral neuroscience, 2016 - frontiersin.org
Down syndrome (DS) is one of the leading causes of intellectual disability, and patients with
DS face various health issues, including learning and memory deficits, congenital heart …

The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target

M Rammohan, E Harris, RS Bhansali, E Zhao, LS Li… - Oncogene, 2022 - nature.com
Dual-specificity tyrosine phosphorylation-regulated kinase 1 A (DYRK1A) is a
serine/threonine kinase that belongs to the DYRK family of proteins, a subgroup of the …

DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis

AJ Laham, M Saber-Ayad, R El-Awady - Cellular and Molecular Life …, 2021 - Springer
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a dual kinase
that can phosphorylate its own activation loop on tyrosine residue and phosphorylate its …

Neurogenesis impairment: An early developmental defect in Down syndrome

F Stagni, A Giacomini, M Emili, S Guidi… - Free Radical Biology and …, 2018 - Elsevier
Down syndrome (DS) is characterized by brain hypotrophy and intellectual disability starting
from early life stages. Accumulating evidence shows that the phenotypic features of the DS …

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease

K Sato, AA Padgaonkar, SJ Baker, SC Cosenza… - Nature …, 2021 - nature.com
Triple negative breast cancer (TNBC) remains challenging because of heterogeneous
responses to chemotherapy. Incomplete response is associated with a greater risk of …

DYRK1A protein, a promising therapeutic target to improve cognitive deficits in Down syndrome

A Feki, Y Hibaoui - Brain sciences, 2018 - mdpi.com
Down syndrome (DS) caused by a trisomy of chromosome 21 (HSA21), is the most common
genetic developmental disorder, with an incidence of 1 in 800 live births. Its phenotypic …